Domestic pharmaceutical and biotech companies are seeking orders and licensing opportunities at global events. Manufacturers are pursuing new customers by highlighting their production facilities and supply capabilities. Drug development companies are also looking for licensing and co-development partners. In-person meetings to introduce new treatments and drug delivery technologies are continuing. However, follow-up discussions are needed before initial talks can lead to actual contracts. Investors should consider the technologies and production competitiveness of companies of interest, along with business results that have been officially confirmed.


If you want to add biotech stocks while waiting to confirm follow-up contracts, but your investment funds are tied up in your existing holdings, you can also consider ways to raise funds using your brokerage account. Depending on the terms of use, stock financing services that allow you to invest up to four times your available funds, including your own capital, are one option for buying more shares in companies of interest and broadening your investment portfolio. By consulting with an advisor to confirm the amount available and financing costs, you can determine a purchase amount that fits your financial capacity while taking your existing investment plans into account.


Hi Stock Loan has maintained its position as the industry's No. 1 provider for 22 years and offers a range of stock financing products, including those with annual interest rates in the 5% range. The service can be used not only to raise new investment funds but also to refinance credit and margin trading balances, attracting investors seeking to secure investment opportunities while reducing their financing burden.

Biotech Partnership News Draws Interest in More Stocks, But What If Funds Are Tight? View original image

[Go to Hi Stock Loan, the industry's No. 1 provider: https://www.hisl.co.kr]


Meanwhile, interest in stock-backed loans is growing day by day. Investors looking to capitalize on a rare investment opportunity are turning to stock-backed loans, which allow them to access more funds to purchase shares.


Another advantage of stock-backed loans is that even if a sharp drop in share prices puts investors using margin or credit trading at risk of forced liquidation, they can switch over simply, without adding collateral or selling shares, and wait for a rebound.


◆ Hi Stock Loan offers industry-low annual interest rates in the 5% range for additional investment funds and refinancing of credit and margin balances!

Hi Stock Loan has launched a securities-linked credit product available at industry-low annual interest rates in the 5% range, so investors can try stock-backed loans without undue burden. The product can be used both to purchase shares and to refinance margin or credit balances with securities firms. Investors can access up to four times their own capital, with no differentiation by credit rating. Investors who use the Alternative Trading System (NXT) can also use the service.


Investors who want to learn about Hi Stock Loan's range of tailored products can contact the customer service center (Tel. 1566-5113) for a convenient consultation with a professional advisor at any time, 24 hours a day, whether or not they qualify for a loan.


○ Launch of a product with industry-low annual interest rates in the 5% range

○ ETF trading available

○ No. 1 market share for 22 consecutive years; Korea First Brand Award winner for 17 consecutive years

○ Real-time repayment of margin and credit balances with securities firms

○ Trading available through the Alternative Trading System (NXT)

○ Reliable consultation quality guarantee program

* Hi Stock Loan Customer Service Center: 1566-5113

Go to: https://www.hisl.co.kr


JUSUNG Engineering, Sammi Metal Products, POSCO Future M, LG Innotek, SK Innovation



※ This content does not reflect the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing